Key stats
About Direxion Daily Healthcare Bull 3X Shares
Expense ratio
0.96%
Home page
Inception date
Jun 15, 2011
As a levered product, CURE is not a buy-and-hold ETF, it's a short-term tactical instrument. Like many levered funds, it delivers 3x exposure only for one day. Over longer periods, returns can vary significantly from 3x of its underlying index, which covers some of the biggest healthcare nameslike J&J, Pfizer, and Merckin the space, and those heavyweights comprise a large share of CURE's cap-weighted, S&P 500-only portfolio. As a short-term product, CURE's expense ratio is less important than all in trading costs. Trading can be volatile. Check the latest Tradability data on this page.
Classification
What's in the fund
Exposure type
Health Technology
Health Services
Cash
Stock breakdown by region
CURE price moved above its 50-day MA on June 19, 2020This price move could indicate a change in the trend, and may be a buy signal for investors. I found 46 similar cases, and 42 were successful. Based on this data, the odds of success are 90%.
Healthcare volatility could be good for swing tradersA recent survey of analysts by FactSet revealed that we're in an "earnings recession" right now and that it's expected to get worse in the next quarter. Certain sectors have been particularly hard hit, namely mining and semiconductors. The sectors that are expected to report the best earnings this q
CURE buy for the LONG (2+ years)Buying at ~53.37. taking profits at red line.
my fair value for this etf is $62 per share.
Long CURE 3:1 Reward/Risk, Risk $100 to make $300.CURE is at the bottom of the longer term trend and we have an opportunity to place a trade for continuation of the trend.
Entry (Stop Limit Buy): Stop $44.77 @ Limit $44.87 (10 cents above previous high)
Stop Loss: $43.18 (10 cents under the previous low)
Profit Target: $49.93 (3x risk)
CURE 3x ETF. Potential 3 drives + DivergenceMessy chart. Some potential buy targets through confluence support shown.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.